Chintalgattu, Vishnu <br/><br/>
Utility of Glycosylated TIMP3 molecules: Inhibition of MMPs and TACE to improve cardiac function in rat myocardial infarct model.  [electronic resource] 

 -  Pharmacology research & perspectives  12 2018 
 - e00442 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2052-1707 
<br/><br/><label>Standard No.: </label>10.1002/prp2.442  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAM17 Protein--antagonists & inhibitors<br/>Animals<br/>Cell Line<br/>Disease Models, Animal<br/>Disease Progression<br/>Extracellular Matrix--drug effects<br/>Fibroblasts<br/>Glycosylation<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intralesional<br/>Male<br/>Matrix Metalloproteinases--metabolism<br/>Mutation<br/>Myocardial Infarction--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Fusion Proteins--chemistry<br/>Tissue Inhibitor of Metalloproteinase-3--chemistry<br/>Treatment Outcome<br/>Ventricular Function, Left--drug effects